These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 22902266

  • 1. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.
    Minai OA, Santacruz JF, Alster JM, Budev MM, McCarthy K.
    Respir Med; 2012 Nov; 106(11):1613-21. PubMed ID: 22902266
    [Abstract] [Full Text] [Related]

  • 2. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM, Gudavalli R, McCarthy K, Parambil J.
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y.
    Respiration; 2013 May; 85(6):456-63. PubMed ID: 23257350
    [Abstract] [Full Text] [Related]

  • 4. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary hypertension in chronic lung diseases.
    Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL.
    J Am Coll Cardiol; 2013 Dec 24; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [Abstract] [Full Text] [Related]

  • 6. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
    Neal JE, Lee AS, Burger CD.
    Clin Respir J; 2014 Oct 24; 8(4):404-9. PubMed ID: 24308300
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
    Harari S, Caminati A, Cassandro R, Conti S, Madotto F, Luisi F, Cesana G.
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan 05; 31(4):297-305. PubMed ID: 25591141
    [Abstract] [Full Text] [Related]

  • 8. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma.
    Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Tröster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H.
    Am J Respir Crit Care Med; 2009 Nov 01; 180(9):881-6. PubMed ID: 19679693
    [Abstract] [Full Text] [Related]

  • 9. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.
    Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF.
    Respir Med; 2006 Oct 01; 100(10):1734-41. PubMed ID: 16545950
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
    Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF.
    Chest; 2006 Mar 01; 129(3):746-52. PubMed ID: 16537877
    [Abstract] [Full Text] [Related]

  • 11. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
    du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE.
    Am J Respir Crit Care Med; 2011 May 01; 183(9):1231-7. PubMed ID: 21131468
    [Abstract] [Full Text] [Related]

  • 12. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
    Lupi-Herrera E, Santos-Martínez LE, Pulido T, Sandoval J.
    Arch Cardiol Mex; 2009 May 01; 79(2):91-103. PubMed ID: 19722378
    [Abstract] [Full Text] [Related]

  • 13. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures.
    Stevens GR, Lala A, Sanz J, Garcia MJ, Fuster V, Pinney S.
    J Heart Lung Transplant; 2009 Sep 01; 28(9):899-905. PubMed ID: 19716042
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.
    Andersen CU, Mellemkjær S, Hilberg O, Nielsen-Kudsk JE, Simonsen U, Bendstrup E.
    Respir Med; 2012 Jun 01; 106(6):875-82. PubMed ID: 22425136
    [Abstract] [Full Text] [Related]

  • 15. Associated Pulmonary Hypertension Is an Independent Contributor to Exercise Intolerance in Chronic Fibrosing Interstitial Pneumonias.
    Yoo DK, Zompatori M, Barrile A, Rossi G, D'Amato D, Sergiacomi G, Rogliani P, Mura M.
    Respiration; 2018 Jun 01; 96(6):543-551. PubMed ID: 30114688
    [Abstract] [Full Text] [Related]

  • 16. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.
    D'Andrea A, Stanziola A, Di Palma E, Martino M, D'Alto M, Dellegrottaglie S, Cocchia R, Riegler L, Betancourt Cordido MV, Lanza M, Maglione M, Diana V, Calabrò R, Russo MG, Vannan M, Bossone E.
    Echocardiography; 2016 Jan 01; 33(1):57-65. PubMed ID: 26096076
    [Abstract] [Full Text] [Related]

  • 17. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
    Nemoto K, Oh-Ishi S, Akiyama T, Yabuuchi Y, Goto H, Nonaka M, Sasatani Y, Tachi H, Arai N, Ishikawa H, Hyodo K, Hase I, Miura Y, Takaku T, Hayashihara K, Saito T.
    BMC Pulm Med; 2019 Sep 02; 19(1):167. PubMed ID: 31477076
    [Abstract] [Full Text] [Related]

  • 18. CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.
    Yagi M, Taniguchi H, Kondoh Y, Ando M, Kimura T, Kataoka K, Furukawa T, Suzuki A, Johkoh T, Hasegawa Y.
    Respirology; 2017 Oct 02; 22(7):1393-1399. PubMed ID: 28488784
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors.
    Zimmermann GS, von Wulffen W, Huppmann P, Meis T, Ihle F, Geiseler J, Leuchte HH, Tufman A, Behr J, Neurohr C.
    Respirology; 2014 Jul 02; 19(5):700-6. PubMed ID: 24697923
    [Abstract] [Full Text] [Related]

  • 20. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S, Lichtblau M, Berlier C, Hasler ED, Schwarz EI, Ulrich S.
    Lung; 2019 Oct 02; 197(5):617-625. PubMed ID: 31263960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.